Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Patterns of Steroid Use and Outcomes in US Patients with Generalized Myasthenia Gravis (gMG) Receiving C5 Inhibitor Therapy (C5IT)

              Author:Lee, Justin   Yee, Karen   Blackowicz, Michael   Rodrigues, Ema   Yegin, Ashley   Sabatella, Guido   

              Session Name:P10: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 3  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P10.011  

              Author Institution:Alexion, AstraZeneca Rare Disease, Boston, MA  Alexion, AstraZeneca Rare Disease, Sharon, MA  

              Patent Foramen Ovale Closure for Secondary Stroke Prevention in Patients Aged 60 or Older Is Safe

              Author:May, Brandon   Swarup, Vijendra   Naik, Hursh   Waters, Michael   Gonzalez, Daniel   Kaur, Supreet   Ashby, Lynn   Teran, Patricia   Schroeder, Tracie   Sheehan, Tiffany   Mawk, Emily   Wang, David   

              Session Name:P10: Cerebrovascular Disease and Interventional Neurology: Innovations in Stroke Therapy and Rehabilitation  

              Topic:Cerebrovascular Disease and Interventional Neurology  

              Program Number:P10.011  

              Author Institution:Barrow Neurological Institute, Phoenix, AZ  Arizona Heart Rhythm Center, Paradise Valley, AZ  St. Joseph's Hospital and Medical Center, Phoenix, AZ  Privia Health, Phoenix, AZ  Arizona Cardiovascular Research Center, Phoenix, AZ  

              Incidence and Characterization of Delayed-onset Movement Disorders Following Thrombolysis or Thrombectomy for Acute Ischemic Stroke: A Retrospective Cohort Study

              Author:Yu, Wenzheng   Shnawa, Aya   Swarz, Jeffrey   Zaidi, Ambreen   Leung, Lester   

              Session Name:P10: Movement Disorders: Tics and Other Hyperkinetic Movement Disorders  

              Topic:Movement Disorders  

              Program Number:P10.011  

              Author Institution:Tufts Medical Center, Boston , MA  Tufts Medical Center, Boston, MA  

              A Two-part, Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Fenebrutinib (Part A) and the Effect of Fenebrutinib on the QT/QTc Interval in Healthy Participants (Part B)

              Author:Xu, Yan   Kuruvilla, Denison   Ratchford, John N.   Qi, Qi   Pan, Lin   Yu, Jiajie   

              Session Name:P10: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 3  

              Topic:Multiple Sclerosis  

              Program Number:P10.011  

              Author Institution:Genentech Inc., South San Francisco, CA  

              31-year-old Male with Patau Syndrome: A Rare Case of Long-term Survival

              Author:Bhandal, Deap   Davies, Devin   Carpenter, Dustin   Spears, Kathleen   

              Session Name:P10: Dementia and Behavioral Neurology: Genetics and Rare Diseases 2  

              Topic:Aging, Dementia, Cognitive, and Behavioral Neurology  

              Program Number:P10.011  

              Author Institution:University of Missouri - Kansas City, St. Joseph, MO  Community Hospital Fairfax, Fairfax, MO